Position in GMED
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$24,358,810
+$348,997 QoQ
Shares Held
282,716
+2.8% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in GMED Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,402,735,885 across 83 Medical Devices names. GMED ranks #12 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,876,810 | $295,362,082 | |
| 2 | SYK |
Stryker Corp
|
633,935 | $208,304,701 | |
| 3 | MDT |
Medtronic plc
|
2,241,292 | $194,207,951 | |
| 4 | BSX |
Boston Scientific Corp
|
2,674,641 | $167,833,722 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,067,753 | $85,505,660 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
763,138 | $54,320,162 | |
| 7 | DXCM |
Dexcom Inc
|
772,557 | $48,516,579 | |
| 8 | STE |
STERIS plc
|
214,808 | $47,500,493 |
All Filings in GMED
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,358,810 | 282,716 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $24,009,813 | 274,995 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,146,932 | 281,944 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $17,184,912 | 291,171 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,652,194 | 295,795 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $24,611,931 | 297,569 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $21,833,435 | 305,192 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,878,902 | 304,846 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $17,623,100 | 328,544 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $18,451,822 | 346,253 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $17,097,176 | 344,354 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $13,533,620 | 227,303 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $12,843,233 | 226,752 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $16,809,900 | 226,335 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,117,314 | 220,200 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,331,375 | 219,654 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,385,550 | 194,979 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $14,419,639 | 199,718 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $14,787,430 | 192,997 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,374,043 | 198,298 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $12,335,356 | 200,022 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $13,101,915 | 200,888 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $9,933,910 | 200,604 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,790,998 | 205,219 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $9,968,053 | 234,377 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||